What is Molnupiravir? First Oral COVID Treatment Developed by Merck Could Be Issued By Year's End

Newsweek via MSN ^ | 10/01/2021 | Xander Landen

[SeekAndFind]

Pharmaceutical company Merck and Florida-based Ridgeback Biotherapeutics announced Friday that they plan to seek emergency approval for an oral antiviral treatment for COVID-19.

If authorized by the Food and Drug Administration (FDA), the drug, molnupiravir, could be the first oral antiviral treatment for patients with COVID-19. Merck said it planned to seek emergency use authorization in the U.S. as soon as possible and added that it will also be submitting applications for the drug to "regulatory agencies worldwide."

The companies said that during a phase 3 trial, molnupiravir "significantly reduced the risk of hospitalization or death" in at-risk patients with mild or moderate cases of COVID-19.

The companies said that an interim analysis found that molnupiravir reduced the risk of hospitalization or death by approximately 50%.

According to the press release jointly issued by the two companies, "7.3 percent of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization (28/385), compared with 14.1 percent of placebo-treated patients (53/377)," the companies said.

The release added that no deaths were reported in patients treated with the new drug. In comparison, eight patients who received placebos died of COVID-19.

In a statement, Robert M. Davis, the chief executive officer and president of Merck, said that the company "will continue to work with regulatory agencies on our applications and do everything we can to bring molnupiravir to patients as quickly as possible."

Wendy Holman, the chief executive officer of Ridgeback Biotherapeutics, said that company hopes molnupiravir, if authorized, "can make a profound impact in controlling the pandemic."

[Blood of Tyrants]

Exactly. They will approve a new high dollar UNPROVEN drug and ignore cheap alternatives. Tell me the “pandemic” isn’t being pushed by big pharma.

[blueplum]

not as good as monoclonals but 50% death reduction is better than nothing for regions where they can’t get to monoclonals or are still without vaccine distribution

[moonhawk]

Did they use aborted baby parts in the development?

[moonhawk]

The FDA approved vaccine is not available in the USA. Bait and switch. The Pfizer vac here is still under an EUA.

[SeekAndFind]

RE: Did they use aborted baby parts in the development?

Vaccines are different from Oral drugs, so I believe the answer is ‘No’.

[DSH]

not as good as monoclonals but 50% death reduction is better than nothing for regions where they can’t get to monoclonals or are still without vaccine distribution

What regions? Uttar Pradesh?

[blueplum]

I think Africa is at about 12%, Southeast asia also lousy on vaccinations. PI, etc.

[blueplum]

the ANTICOV study in Africa is all about low cost proven drugs. It’s being run in 18 african nations. They’re trialing Nitazoxanide which is pretty cheap. Ivermectin is being widely phased out because of drug resistance.
https://journals.asm.org/doi/10.1128/AAC.00713-16
https://pubmed.ncbi.nlm.nih.gov/27246778/

molnupiravir was in development before 2020, as EID-2801. It works by injecting errors into the viral dna via “nucleoside analogs’, like remdisivir works but may overcome virus that is already remdisiver-resistant
April 2020
https://pubmed.ncbi.nlm.nih.gov/32253226/
and in formal trials back in Jan 2021
https://pubmed.ncbi.nlm.nih.gov/33273742/
and talked up in Mar 2021
https://pubmed.ncbi.nlm.nih.gov/33561864/

[wgmalabama]

Kill the last 35% ?

[Pollard]

Molnupiravir ©

Take the Red Pill ©

Active Ingredients

• Stromectol 18mg
• Doxycycline 100mg
• Elemental Zinc 300mg
• Vitamin D3 10000iu

[Pollard]

Remdesivir ©

RunDeathIsNear ⪧

[Kickaha]

Thor’s hammer?

[David Chase]

But, but there needs to be 10 years of trials and studies……..

The FDA is planning on Emergency Use approval.

Two terrible things I’ve heard for months and months……

🤔